[Respiratory disease registries in Spain: fundamentals and organization].
暂无分享,去创建一个
Ignacio Blanco | M. Miravitlles | M. Monreal | I. Blanco | Marc Miravitlles | Beatriz Lara | Pilar Morales | Montserrat Vendrell | Javier de Gracia Roldán | Manel Monreal | Ramon Orriols | Isabel Isidro | Khalil Abú-Shams | Pilar Escribano | Victoria Villena | Teresa Rodrigo | Rafael Vidal Plà | Mariano García-Yuste | P. Escribano | P. Morales | V. Villena | B. Lara | M. Vendrell | J. de Gracia Roldán | R. Orriols | Isabel Isidro | K. Abú-Shams | T. Rodrigo | R. Vidal Plà | M. García-Yuste
[1] J. Zock,et al. Reported occupational respiratory diseases in three Spanish regions. , 2010, American journal of industrial medicine.
[2] J. Barberà,et al. Spanish Registry Of Pulmonary Arterial Hypertension (REHAP): Epidemiological Analysis Of Patients With Pulmonary Arterial Hypertension And Chronic Thromboembolic Pulmonary Hypertension In Spain , 2010, ATS 2010.
[3] M. Casals,et al. Tuberculosis treatment adherence and fatality in Spain , 2009, Respiratory research.
[4] Nancy A Dreyer,et al. Registries for robust evidence. , 2009, JAMA.
[5] A. Orcau,et al. Factors Associated with Differences between Conventional Contact Tracing and Molecular Epidemiology in Study of Tuberculosis Transmission and Analysis in the City of Barcelona, Spain , 2008, Journal of Clinical Microbiology.
[6] R. Coll,et al. Diagnóstico y tratamiento de las bronquiectasias , 2008 .
[7] M. Monreal,et al. Venous thromboembolism in Spain. Comparison between an administrative database and the RIETE registry. , 2008, European journal of internal medicine.
[8] J. A. Caylà,et al. Diagnóstico y tratamiento de la tuberculosis , 2008 .
[9] P. Prandoni,et al. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism , 2008, Thrombosis and Haemostasis.
[10] M. Monreal,et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry , 2008, Thrombosis and Haemostasis.
[11] M. Monreal,et al. Gammagrafía pulmonar y tomografía computarizada helicoidal en el diagnóstico de embolia pulmonar en España. Datos del Sistema Nacional de Salud y el Registro RIETE , 2008 .
[12] S. Laporte,et al. Thromboembolism : Findings From the Registro Informatizado de la Enfermedad Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous , 2008 .
[13] J. A. Barberá,et al. Estándares asistenciales en hipertensión pulmonar* Documento de consenso elaborado por la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y la Sociedad Española de Cardiología (SEC) , 2008 .
[14] M. Gómez,et al. Estándares asistenciales en hipertensión pulmonar , 2008 .
[15] M. García-Yuste,et al. Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung , 2007, Cancer.
[16] Moira C McKinnon,et al. Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease , 2007 .
[17] M. Miravitlles,et al. Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency , 2007, International journal of chronic obstructive pulmonary disease.
[18] R. Stockley,et al. Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development , 2007, European Respiratory Journal.
[19] Paul Glasziou,et al. When are randomised trials unnecessary? Picking signal from noise , 2007, BMJ : British Medical Journal.
[20] A. Cueto,et al. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] R. Vidal,et al. Diagnóstico y tratamiento del déficit de alfa-1-antitripsina , 2006 .
[22] M. Miravitlles,et al. Déficit de alfa-1-antitripsina. Situación en España y desarrollo de un programa de detección de casos , 2006 .
[23] J. Zock,et al. Reported occupational respiratory diseases in Catalonia , 2006, Occupational and Environmental Medicine.
[24] J. Pérez-Arellano,et al. Helmintos y aparato respiratorio , 2006 .
[25] M. C. M. García. Bronquiectasias: ¿todavía una enfermedad huérfana? , 2005 .
[26] L. Cerezal,et al. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). , 2000, The Annals of thoracic surgery.
[27] M. Miravitlles,et al. Estado actual del tratamiento sustitutivo en el enfisema congénito por déficit de alfa-1-antitripsina. Informe del Registro Nacional , 1999 .
[28] J. Manzano. Diagnóstico y tratamiento de la tuberculosis , 2008 .
[29] J. Barberà,et al. Standards of care in pulmonary hypertension. , 2008, Revista espanola de cardiologia.
[30] L. M. López-Rodó. Tendencias en los factores pronósticos de los tumores pulmonares neuroendocrinos , 2007 .
[31] B. Infante,et al. Registro de enfermedades respiratorias de origen laboral en Navarra Registry of occupational respiratory diseases in Navarre , 2005 .
[32] B. Infante,et al. Mesotelioma pleural maligno , 2005 .